Abeykoon, Jithma P.
Zanwar, Saurabh http://orcid.org/0000-0001-5074-8453
Dispenzieri, Angela
Gertz, Morie A.
Leung, Nelson http://orcid.org/0000-0002-5651-1411
Kourelis, Taxiarchis
Gonsalves, Wilson
Muchtar, Eli http://orcid.org/0000-0003-2210-2174
Dingli, David
Lacy, Martha Q.
Hayman, Suzanne R.
Buadi, Francis
Warsame, Rahma
Kyle, Robert A.
Rajkumar, Vincent
Kumar, Shaji http://orcid.org/0000-0001-5392-9284
Kapoor, Prashant
Article History
Received: 26 June 2018
Revised: 15 August 2018
Accepted: 21 August 2018
First Online: 28 September 2018
Compliance with ethical standards
:
: Dr. Gertz has received funding from Amgen, Prothena, Annexon, Appellis, Johnson and Johnson and Celgene. Dr. Dispenzieri has received research funding from Jannsen, Takeda, Celgene, Pfizer, Alnylam, Prothena, and GSK and serves on the advisory board for Takeda and Intellia. Dr. Kumar received research grants for clinical trials from Celgene, Takeda, Janssen, BMS, Sanofi, KITE, Merck, Abbvie, Medimmune, Novartis, Roche-Genentech, Amgen. Dr. Leung serves on the advisory board for Takeda and Prothena. Dr. Kapoor is principal investigator on studies for which Mayo Clinic receives funding from Takeda, Sanofi, and Amgen. The remaining authors declare no conflicts of interest.